Membrane tumor necrosis factor-α (TNF-α) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation - Characterization of membrane TNF-α

Clinical Immunology and Immunopathology

Volumn 82, Issue 2, 1997, Pages 133-140

  Higuchi, Masanori ^b   Nagasawa, Kohei ^a   Horiuchi, Takahiko ^b   Oike, Masahiro ^b   Ito, Yushi ^b   Yasukawa, Masaki ^c   Niho, Yoshiyuki ^b  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031081260     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4291     Document Type: Article

References (35)

1. 1. Old, L. J., Tumor necrosis factor. Science 230, 630-632, 1985.
2. 2. Kriegler, M., Perez, C., DeFay, K, Albert, I., and Lu, S. D., A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF. Cell 53, 45-53, 1988.
3. + T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177, 1575-1585, 1993.
4. 4. Macchia, D., Almerigogna, F., Parronchi, P., Ravina, A., Maggi, E., and Romagnani, S., Membrane tumor necrosis factor-α is involved in the polyclonal B cell activation induced by HIV-infected human T cells. Nature 363, 464-466, 1993.
5. 5. Tanaka, Y., Fukudome, K., Hayashi, M., Takagi, S., and Yoshie, O., Induction of ICAM-1 and LFA-3 by tax 1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult T-cell leukemia cell lines. Int. J. Cancer 60, 554-561, 1995.
6. 6. Wake, A., Tanaka, Y., Nakatsuka, K., Misago, M., Oda, S., Morimoto, I., and Eto, S., Calcium-dependent homotypic adhesion through leukocyte function-associated antigen-1/intracellular adhesion molecule-1 induces interleukin 1 and parathyroid hormone-related protein production on adult T cell leukemia cells in vitro. Blood 86, 2257-2267, 1995.
7. 7. Kobayashi, N., Hamamoto, Y., and Yamamoto, N., Production of tumor necrosis factors by human T cell lines infected with HTLV-I may cause their high susceptibility to human immunodeficiency virus infection. Med. Microbiol. Immunol. 179, 115-122, 1990.
8. 8. Ferran, C., Dautry, F., Mérite, S., Sheehan, K, Schreiber, R., Grau, G., Bach, J. F., and Chatenoud, L., Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J. Clin. Invest. 93, 2189-2196, 1994.
9. 9. Castle, B. E., Kishimoto, K., Stearns, C., Brown, M. L., and Kehry, M. R., Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151, 1777-1788, 1993.
10. 10. Splawski, J. B., Fu, S. M., and Lipsky, P. E., Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 150, 1276-1285, 1993.
11. 11. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovitch, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., Roberts, R. L., Noelle, R. J., Ledbetter, J. A., Francke, U., and Ochs, H. D., The CD40 ligand, gp39 is defective in activated T cells from patients with X-linked hyper IgM syndrome. Cell 72, 291-300, 1993.
12. 12. Thoma, B., Grell, M., Pfizenmaier, K., and Scheurich, P., Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J. Exp. Med. 172, 1019-1023, 1990.
13. 13. Tsujimoto, M., Yip, Y. K., and Vilcek, J., Tumor necrosis factor: Specific binding and internalization in sensitive and resistant cells. Proc. Natl. Acad. Sci. USA 82, 7626-7630, 1985.
14. 14. Grell, M., Douni, E., Wajant, H., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., and Scheurich, P., The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793-802, 1995.
15. 15. Beutler, B., Greenwalt, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., and Cerami, A. Identity of tumour necrosis factor and the macrophage secreted factor cachectin. Nature 316, 552-554, 1985.
16. 16. Pfizenmaier, K., Scheurich, P., Schlüter, C., and Krönke, M., Tumor necrosis factor enhances HLA-A, B, C and HLA-DR gene expression in human tumor cells. J. Immunol. 138, 975-980, 1987.
17. 17. Yokota, S., Geppert, T. D., and Lipsky, P. E. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-α. J. Immunol 140, 531-536, 1988.
18. 18. Kehrl, J. H., Miller, A., and Fauci, A. S., Effect of tumor necrosis factor α on mitogen-activated human B cells. J. Exp. Med. 166, 786-791, 1987.
19. 19. Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Woolley, K., Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370, 555-557, 1994.
20. 20. McGeehan, G. M., Becherer, J. D., Bast, R. C., Jr., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B., Nichols, J., Pryzwansky, K. M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J., and Ways, J. P., Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370, 558-561, 1994.
21. 21. Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L., and Kriegler, M., A nonsecretable cell surface mutant of tumour necrosis factor (TNF) kills by cell-to-cell contact. Cell 63, 251-258, 1990.
22. 22. Vandenabeele, P., Declercq, W., Vercammen, D., Van de Craen, M., Grooten, J., Loetscher, H., Brockhaus, M., Lesslauer, W., and Fiers, W., Functional characterization of the human tumour necrosis factor receptor p75 in a transfected Rat/Mouse T cell hybridoma. J. Exp. Med. 176, 1015-1024, 1992.
23. 23. Jumper, M. D., Nishioka, Y., Davis, L. S., Lipsky, P. E., and Meek, K., Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J. Immunol. 155, 2369-2378, 1995.
24. 24. Müller, R., Marmenout, A., and Fiers, W., Synthesis and maturation of recombinant human tumor necrosis factor in eukaryotic systems. FEBS Lett. 197, 99-104, 1986.
25. 25. Utsumi, T., Levitan, A., Hung, M. C., and Klostergaard, J., Effects of truncation of human pro-tumor necrosis factor transmembrane domain on cellular targeting. J. Biol. Chem. 268, 9511-9516, 1993.
26. 26. Gallin, E. K., Ion channels in leukocytes. Physiol. Rev. 71, 775-811, 1991.
27. 2+-ATPaSe inhibitors. J. Immunol. 152, 5226-5240, 1994.
28. 28. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Hiroyoko, A., Igata, A., Matsumoto, M., and Tara, M., HTLV-I-associated myelopathy, a new clinical entity. Lancet i, 1031-1032, 1986.
29. 29. Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A., and de The, G., Antibodies to human-T lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii, 407-409, 1985.
30. 30. Nishioka, K., Maruyama, I., Sato, K, Kitajima, L, Nakajinla, Y., and Osame, M., Chronic inflammatory arthropathy associated with HTLV-I. Lancet i, 441, 1989.
31. 31. Sagawa, K, Mochizuki, M., Masuoka, K., Katagiri, K., Katayama, T., Maeda, T., Tanimoto, A., Sugita, S., Watanabe, T., and Itoh, K., Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis, detection of HTLV-I infected T cells in the eye and their constitutive cytokine production. J. Clin. Invest. 95, 852-858, 1995.
32. 32. Terada, K, Katamine, S., Eguchi, K, Moriuchi, R., Kita, M., Shimada, H., Yamashita, I., Iwata, K., Tsuii, Y., Nagataki, S., and Miyamoto, T., Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 344, 1116-1119, 1994.
33. 33. Sumida, T., Yonaha, F., Maeda, T., Kita, Y., Iwamoto, I., Koike, T., and Yoshida, S., Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjögren's syndrome. Arthritis Rheum. 37, 545-550, 1994.
34. 34. Moutsopoulous, H. M., and Manoussakis, M. N., Immunopathogenesis of Sjögren's syndrome: "Facts and Fancy." Autoimmunity 5, 17-24, 1989.
35. 35. Nakagawa, M., Izumo, S., Ijichi, S., Kubota, H., Arimura, K., Kawabata, M., and Osame, M., HTLV-I associated myelopathy: Analysis of 213 patients based on clinical features and laboratory findings. J. Neurovirol. 1, 50-61, 1995.